eMed Support Systems is a Dubai- and Cyprus-based health-tech startup founded in 2023, focused on transforming cardiovascular care through AI-powered clinical decision support. The company is located in Dubai Internet City and operates with a compact multidisciplinary team.

eMed develops digital patient twins that analyze over 120 clinical parameters from electronic health records. Their platform applies clinical guideline–based algorithms and predictive AI to identify patients at risk, suggest evidence-based therapies, and monitor progression for conditions such as LDL-cholesterol elevation, GFR decline, and cardiac dysfunction.

Clinicians use eMed’s actionable dashboards and patient-specific reports to prioritize high-risk cases, adjust treatments, and optimize follow-up. The system can reduce the clinician’s assessment time—traditionally 40 minutes for multiple variables—to under one minute by auto-generating insights and recommendations.

The platform serves health authorities and private care providers, helping reduce costs, improve treatment adherence, and support proactive disease management. Its AI models predict missing clinical indicators and flag patient groups most likely to deviate from treatment goals.

Founded by medical and data science experts, eMed Support Systems combines real-world data, clinical knowledge, and self-supervised modeling to power predictive healthcare. Their goal is to enhance outcomes, streamline workflows, and support early intervention for chronic cardiovascular patients across the MENA region.